You are here

Article info

Article menu
XML
Pancreatic cancer
Original article
SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice

Authors

  1. Correspondence to Dr David A Tuveson, Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA; dtuveson{at}cshl.edu
View Full Text

Citation

Neesse A, Frese KK, Chan DS, et al
SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice
Gut 2014;63:974-983.

Publication history

  • Received July 1, 2013
  • Revised July 24, 2013
  • Accepted July 28, 2013
  • First published September 25, 2013.
Online issue publication 
April 18, 2016

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/